The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2019

Filed:

Jun. 11, 2015
Applicants:

Riken, Wako-shi, Saitama, JP;

Animal Allergy Clinical Laboratories Inc., Sagamihara-shi, Kanagawa, JP;

Nippon Zenyaku Kogyo Co., Ltd., Koriyama-shi, Fukushima, JP;

Inventors:

Kenichi Masuda, Sagamihara, JP;

Yasuyuki Ishii, Wako, JP;

Toshihiro Tsukui, Koriyama, JP;

Assignees:

RIKEN, Wako-shi, Saitama, JP;

Animal Allergy Clinical Laboratories Inc., Sagamihara-shi, Kanagawa, JP;

Nippon Zenyaku Kogyo Co., Ltd., Koriyama-shi, Fukushima, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 7/08 (2006.01); A61K 39/39 (2006.01); C07K 16/42 (2006.01); C07K 17/02 (2006.01); A61K 39/395 (2006.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 39/00 (2013.01); A61K 39/39 (2013.01); A61K 39/3955 (2013.01); C07K 16/18 (2013.01); C07K 16/42 (2013.01); C07K 17/02 (2013.01); A61K 2039/55522 (2013.01); C07K 2317/34 (2013.01);
Abstract

The present invention provides a synthetic peptide capable of inducing an antibody to an autoantigen, and specifically, provides: a multiplexed same type-antigenic peptide having a dendritic core and B-cell recognition peptides, wherein the multiplexed same type-antigenic peptide comprises 4 to 8 B-cell recognition peptides of the same type that are bound to the terminal ends of the dendritic core directly or via a spacer, and each B-cell recognition peptide is bound to the terminal end of the dendritic core directly or via a spacer; an antibody production-inducing agent having the peptides; and a method for producing the peptide.


Find Patent Forward Citations

Loading…